Faculty, Staff and Student Publications Publication Date 3-5-2026 DOI 10.1136/bcr-2025-269690 PubMedCentral® Posted Date 3-5-2026 PubMedCentral® Full Text Version Post-print Abstract This report describes a female patient in her 60s with an immune-mediated necrotising myopathy (IMNM) occurring after semaglutide use. She was found to have progressive dysphagia, dysphonia, proximal muscle weakness and creatine kinase elevation over a 4-month course.